You are currently viewing a new version of our website. To view the old version click .
MDPIMDPI
Search all articles
BioMed
Submit to BioMed
  • 33 daysTime to First Decision

BioMed, Volume 3, Issue 2

June 2023 - 9 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (9)

  • Review
  • Open Access
4 Citations
3,403 Views
27 Pages
Download PDF

Converging Paths: A Comprehensive Review of the Synergistic Approach between Complementary Medicines and Western Medicine in Addressing COVID-19 in 2020

  • Alexandra Moura,
  • Lara Lopes,
  • Luís Carlos Matos,
  • Jorge Machado and
  • Maria Begoña Criado
BioMed2023, 3(2), 282-308;https://doi.org/10.3390/biomed3020025

6 June 2023

The rapid spread of the new coronavirus disease (COVID-19) caused by SARS-CoV-2 has become a global pandemic. Although specific vaccines are available and natural drugs are being researched, supportive care and specific treatments to alleviate sympto...

Full Article
  • Article
  • Open Access
2 Citations
2,250 Views
10 Pages
Download PDF

Clinical Characteristics, Outcomes, and Risk Factors of Patients Hospitalized for COVID-19 across the Latest Pandemic Waves: Has Something Changed?

  • Mariacristina Poliseno,
  • Edoardo Paolo Drago,
  • Melita Anna Poli,
  • Maurantonio Altamura,
  • Serena Rita Bruno,
  • Angela Calamo,
  • Anna Giannelli,
  • Giovanni Infante,
  • Michele Mazzola and
  • Damiana Moschetta
  • + 3 authors
BioMed2023, 3(2), 272-281;https://doi.org/10.3390/biomed3020024

30 May 2023

Despite the availability of vaccines and antivirals and the biological evolution of SARS-CoV-2, the rate of hospitalizations and deaths from COVID-19 remains high in Italy. It is crucial to understand whether and how the clinical characteristics of p...

Full Article
  • Opinion
  • Open Access
10 Citations
10,397 Views
16 Pages
Download PDF

Public Health Needs the Public Trust: A Pandemic Retrospective

  • Matthew T. J. Halma and
  • Joshua Guetzkow
BioMed2023, 3(2), 256-271;https://doi.org/10.3390/biomed3020023

30 May 2023

The COVID crisis of the past three years has greatly impacted stakeholder relationships between scientists, health providers, policy makers, pharmaceutical industry employees, and the public. Lockdowns and restrictions of civil liberties strained an...

Full Article
  • Review
  • Open Access
13 Citations
6,692 Views
10 Pages
Download PDF

Machine Learning and Artificial Intelligence for Pathogen Identification and Antibiotic Resistance Detection: Advancing Diagnostics for Urinary Tract Infections

  • Mohammed Harris
BioMed2023, 3(2), 246-255;https://doi.org/10.3390/biomed3020022

30 May 2023

Machine learning is being increasingly applied in various aspects of medicine. The availability of large amounts of digital health records has enabled researchers to apply machine learning algorithms to tackle different medical problems. Urinary trac...

Full Article
  • Article
  • Open Access
2,465 Views
10 Pages
Download PDF

Real-Life Advantages and Limits of Baricitinib for the Late Treatment of Adults Hospitalized with COVID-19

  • Mariacristina Poliseno,
  • Donato Lacedonia,
  • Mariangela Niglio,
  • Federica De Gregorio,
  • Graziano Antonio Minafra,
  • Terence Campanino,
  • Giulio Giganti,
  • Giulia Scioscia,
  • Teresa Antonia Santantonio and
  • Maria Pia Foschino Barbaro
  • + 1 author
BioMed2023, 3(2), 236-245;https://doi.org/10.3390/biomed3020021

8 May 2023

Baricitinib, a reversible Janus-associated kinase-inhibitor, is approved for treating COVID-19, combined with Dexamethasone and, eventually, with Remdesivir (RDV). This retrospective cohort study assesses the real-life advantages and limits of Barici...

Full Article
  • Article
  • Open Access
2,328 Views
11 Pages
Download PDF

Retrospective Comparison of Hospital Outcomes among Mechanically Ventilated COVID-19 Patients in ICU Who Received Methylprednisolone or Dexamethasone

  • Mariangela Canaan,
  • Kelsey N. Williams,
  • Md Ashfaq Ahmed,
  • Zhenwei Zhang,
  • Venkataraghavan Ramamoorthy,
  • Peter McGranaghan,
  • Muni Rubens and
  • Anshul Saxena
BioMed2023, 3(2), 225-235;https://doi.org/10.3390/biomed3020020

10 April 2023

Background: A number of corticosteroids are commonly used to treat COVID-19 infection. The aim of this retrospective study was to compare various hospital outcomes among mechanically ventilated COVID-19 patients in an ICU, who were administered eithe...

Full Article
  • Communication
  • Open Access
2 Citations
1,773 Views
8 Pages
Download PDF

A Longitudinal Assessment of Substance Use Treatment during the COVID-19 Pandemic Using Staff and Service Data

  • Molly Carlyle,
  • Grace Newland,
  • Leith Morris,
  • Rhiannon Ellem,
  • Calvert Tisdale,
  • Catherine A. Quinn and
  • Leanne Hides
BioMed2023, 3(2), 217-224;https://doi.org/10.3390/biomed3020019

4 April 2023

Introduction: Alcohol and other drug (AOD) treatment services were required to rapidly adapt delivery of care in response to the coronavirus (COVID-19) pandemic. This study examined longitudinal changes in the delivery of AOD counselling in Australia...

Full Article
  • Article
  • Open Access
1,823 Views
10 Pages
Download PDF

External Validation of the ImAgeS Risk Score for Mortality in Hospitalized Kidney Transplant Recipients with COVID-19: A Retrospective Observational Study

  • Josipa Domjanović,
  • Tea Domjanović Škopinić,
  • Tea Gamberažić Kirevski and
  • Andrija Matetic
BioMed2023, 3(2), 207-216;https://doi.org/10.3390/biomed3020018

4 April 2023

Background: Timely recognition of high-risk individuals with novel Coronavirus disease (COVID-19) is important. Yet, validated risk scores for kidney transplant recipients with COVID-19 are lacking. The present study aimed to externally validate the...

Full Article
  • Interesting Images
  • Open Access
1 Citations
2,111 Views
5 Pages
Download PDF

Obliterative Endotheliitis Leading to Cystic Lung Necrosis in Severe COVID-19 during the First Wave of the Pandemic

  • Clémence Delteil,
  • Julien Carvelli,
  • Lionel Velly,
  • Laurent Daniel,
  • Caroline Capuani,
  • Julia Torrents,
  • Marc Gainnier,
  • Nicolas Bruder,
  • Marie-Dominique Piercecchi-Marti and
  • Pierre Simeone
BioMed2023, 3(2), 202-206;https://doi.org/10.3390/biomed3020017

23 March 2023

In the early months of the outbreak (2020–2022), COVID-19 was responsible for acute respiratory distress syndrome (ARDS) and an exceptional number of intensive care unit (ICU) admissions. Weaning difficulties from invasive mechanical ventilatio...

Full Article

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
BioMed - ISSN 2673-8430
Imprint